It has previously been reported that mice heterozygous for a null mutation of the Cdx2 gene develop multiple intestinal adenomatous polyps, most notably in the proximal colon (Chawengsaksophak et al., 1997) . In fact on further analysis these murine tumours have been shown to consist mainly of foregut tissues including gastric glandular epithelium as well as the squamous mucosa noted originally. Whilst the lesions combine foregut heterotopia with epithelial overgrowth and are likely to be clonal, they lack the cytological atypia and marked architectural disorganization typical of intestinal adenomas and must be clearly distinguished from the latter. This implies that the intestinal polyps in the murine model are primarily developmental rather than neoplastic, consistent with their occurrence in early life. However, it is not known whether these lesions would progress to neoplasia given an appropriate time span.
In the adult mouse Cdx2 is expressed exclusively in intestinal epithelium, with highest levels in the proximal colon (James et al., 1994) . Epithelial cells from the tumours of Cdx2 heterozygous mice show no expression of the Cdx2 protein (Chawengsaksophak et al., 1997) , consistent with ®ndings of reduced or absent expression in rat and human colorectal tumours (Ee et al., 1995) . In addition, mRNA expression was shown to be reduced or absent in a number of human colorectal adenocarcinomas and colon-cancer cell lines (Mallo et al., 1997) . These observations further strengthened our hypothesis that mutation of human CDX2 may be involved in the molecular pathology of a subset of colorectal tumours.
In order to allow the entire coding region of CDX2 to be searched for mutations, we determined the genomic sequence at each of the intron/exon boundaries. The sequence of the human CDX2 coding sequence was available (Accession number HSU51096), and by extrapolation from the mouse gene was assumed to consist of three exons. Initially primers were designed to amplify a 394 bp fragment primarily from the 3'UTR of human CDX2, and this fragment was used to screen a human liver genomic phage library (Promega). Positive clones were puri®ed and appropriate fragments were subcloned for sequencing. Due to the high degree of conservation between the mouse and human genes, the location of intron/ exon boundaries was also assumed to be approximately conserved. Primers were therefore designed to sequence out of each exon into the intronic sequence, with the exception of 5' of exon 1 and 3' of exon 3 where UTR sequence could be used. Based on intronic and UTR sequence, primers were designed to amplify the three coding exons of human CDX2 (Figure 1 ).
Mutation searching was performed by a combined single strand conformational polymorphism (SSCP) and heteroduplex analysis in 85 colorectal carcinomas. The tumour cohort contained 36 females and 49 males ranging in age from 33 ± 85 years (mean, 68 years). Fifty-three tumours were right-sided (proximal to the splenic¯exure), 29 tumours were left-sided (distal to the splenic¯exure) and no information was available for three tumours. Of 85 tumours, 11 were Dukes' stage A, 34 were stage B, 24 were stage C and 12 were stage D (4 unknown).
Of the 85 tumours analysed, 45 were RER+ and 40 were RER7. RER+ tumours are characterized by insertion or deletion of repeat units within repetitive DNA. This microsatellite instability occurs most often in noncoding DNA, although several genes have been shown to be inactivated by mutations within microsatellites in coding regions in colorectal cancers (Markowitz et al., 1995; Souza et al., 1996; Rampino et al., 1997) .
In total, six independent alterations were detected. The ®rst was a polymorphism in exon one (G250C) which did not alter the encoded amino acid (P60P). The remaining alterations were found in exon 3, the only exon which contained repetitive regions consistent with targets for replication errors. Of the changes, two were found to be polymorphisms, one was a silent mutation and two are assumed to be disease-associated mutations. The polymorphisms were located outside repeat regions, and while both altered amino acid residues (P282L, S291P) these changes were also found in normal mucosa. The silent mutation was a T to G transversion (T847G) found in only one tumour, and while it was not present in the corresponding normal mucosa, it did not alter the encoded amino acid (P259P).
The remaining two alterations were found in the same RER+ tumour (instability demonstrated at 6/6 microsatellite loci examined) and are both consistent with repeat instability (Figure 1) . One of these was a three base pair deletion which altered a trinucleotide repeat sequence from 5'-AAC AAG AAG AAG-3' to 5'-AAC AAG AAG-3'. This resulted in the in-frame deletion of a single lysine residue (delK244). This trinucleotide repeat is located one residue upstream of a larger repeat region containing 23 glutamine and proline residues. The second change was a deletion of a single nucleotide from a string of seven G's located 23 nucleotides upstream of the stop codon (974delG), resulting in a frameshift and premature truncation of the CDX2 protein involving the last eight amino acids. Neither of these changes is present in the patient's normal mucosa. Cloning and sequencing revealed that the mutations occurred on dierent alleles thus eecting the two-hit scenario of a tumour suppressor gene, although it is not known de®nitively if either or both of these mutations lead to inactivation of the respective allele. If CDX2 acts as a tumour suppressor gene in some human colorectal tumours, this is in contrast to the mouse lesions which occur in mice heterozygous for the Cdx2 null mutation (Chawengsaksophak et al., 1997) . Cdx2 homozygote null mutant mice do not survive the peri-implantation period, and die between 3.5 and 5.5. days post coitum. Analysis of lesions from heterozygous mice revealed that the normal allele was not lost, despite absence of Cdx2 protein expression (Chawengsaksophak et al., 1997) .
The tumour which showed two alterations in CDX2 was located in the proximal colon of a 73 year old female and was classi®ed as Dukes' stage B. This tumour has previously been examined for frameshift mutations in the coding repeat sequences of TGFbRII, IGF2R and BAX (A 10 , G 8 and G 8 respectively), all of which have been shown to be mutated in a subset of RER+ colorectal tumours (Markowitz et al., 1995; Souza et al., 1996; Rampino et al., 1997) . However, despite the fact that this tumour shows extensive microsatellite instability at other loci, no frameshift mutations were detected in repeat sequences within these three genes (Lisa Simms, unpublished data) .
Since the polyps seen in CDX2 heterozygote mice showed obvious gastric heterotopia, similar changes might be expected to occur in human colorectal cancers with CDX2 mutations. However, the human adenocarcinoma showing two alterations in CDX2 had classical intestinal type goblet cells secreting acid . Arrows indicate aberrant bands seen in the tumour which were not seen in any of the other samples analysed. The primers used ampli®ed exon three of human CDX2, and the sequence is as follows, CE3F 5'-ACTGATGGGTACTGTTCCTC-3', CE3R 5'-CTCAGCCTG-GAATTGCTCTG-3'. Primers for exon 1 were: CE1Fa 5'-CTGGCAGCCTTCAACGTC-3', CE1Ra 5'-GTAGCCATTC-CAGTCCTC-3' and CE1Fb 5'-AGGACTGGAATGGCTACGC-3', CE1Rb 5'-CAGCAGCCACTGGCTCGA-3'; and exon 2: CE2F 5'-AGGTTTGTCATTACCCATG-3', CE2R 5'-TAACTCTCATGGTCCTTGC-3'. All PCR reactions were performed in the presence of [a-33 P]dCTP and were standard, with the exception of both exon 1 reactions which contained 5% formamide. Samples were electrophoresed under two conditions: 6% polyacrylamide (2.6% crosslinking), 45W, 48C and 6% polyacrylamide (2.6% crosslinking), 10% glycerol, 60W, room temperature. (b) Altered sequence seen on each of the alleles of the mutant tumour as compared to the wild type sequence mucins, indicating that lesions seen in a murine model may not always exactly mirror the course of human disease (Figure 2 ). Though the pattern of expression of Cdx2 is essentially the same in mouse and human, it is likely that subtle dierences present in the genetic background of each tissue ultimately determine the phenotypic lineage of a tumour.
While several discrepancies exist between the occurrence of intestinal polyps in the colon of Cdx2 heterozygous mice and the pathology of human colorectal cancer, our results suggest that in some cases mutations in the CDX2 gene caused by repeat instability may underly human colorectal tumorigenesis.
